|
Zenith abstract at AACR
|
8
|
Resverlogix Corp.
|
Oct 26, 2015 10:57PM
|
|
For Toniv, Re:Zenith
|
5
|
Resverlogix Corp.
|
Oct 29, 2015 10:00PM
|
|
Re: ... a full plate..
|
6
|
Resverlogix Corp.
|
Nov 02, 2015 02:05PM
|
|
Re: ... a full plate..
|
4
|
Resverlogix Corp.
|
Nov 02, 2015 02:41PM
|
|
Re: fda
|
5
|
Resverlogix Corp.
|
Nov 03, 2015 12:52PM
|
|
Re: … Zack’s analyst report's impact...
|
4
|
Resverlogix Corp.
|
Nov 04, 2015 01:05PM
|
|
Re: … Zack’s analyst report's impact...
|
1
|
Resverlogix Corp.
|
Nov 04, 2015 03:28PM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
3
|
Resverlogix Corp.
|
Nov 05, 2015 11:10AM
|
|
Stonegate Capital Partners Initiates Coverage on Resverlogix
|
8
|
Resverlogix Corp.
|
Nov 05, 2015 04:31PM
|
|
Re: Stonegate Capital Partners Initiates Coverage on Resverlogix
|
7
|
Resverlogix Corp.
|
Nov 05, 2015 04:44PM
|
|
What will Monday bring?
|
5
|
Resverlogix Corp.
|
Nov 06, 2015 02:19PM
|
|
American Heart Association Abstract for Sunday 11/8/15
|
4
|
Resverlogix Corp.
|
Nov 06, 2015 08:07PM
|
|
Re: empagliflozin - a drug competitive to rvx-208???
|
6
|
Resverlogix Corp.
|
Nov 08, 2015 09:41PM
|
|
Re: empagliflozin - a drug competitive to rvx-208???
|
3
|
Resverlogix Corp.
|
Nov 08, 2015 09:47PM
|
|
Re: ... a number of things come to mind
|
7
|
Resverlogix Corp.
|
Nov 08, 2015 10:13PM
|
|
Re: After the dust settles in 3 weeks
|
4
|
Resverlogix Corp.
|
Nov 09, 2015 10:46AM
|
|
Re: It seems ...
|
5
|
Resverlogix Corp.
|
Nov 09, 2015 05:46PM
|
|
Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
2
|
Resverlogix Corp.
|
Nov 11, 2015 11:47AM
|
|
Re: Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
6
|
Resverlogix Corp.
|
Nov 11, 2015 11:50AM
|
|
Seeking Alpha news on Resverlogix's lead product candidate for CV disease
|
4
|
Resverlogix Corp.
|
Nov 11, 2015 12:08PM
|
